Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells

Journal of Cell Science

Volumn 114, Issue 22, 2001, Pages 4073-4081

  Dormer, R L ^a   Derand R ^a   McNeilly, C M ^a   Mettey, Y ^a   Bulteau Pignoux, L ^a   Metaye T ^a   Vierfond, J M ^a   Gray, M A ^a   Galietta, L J V ^a   Morris, M R ^a   Pereira, M M ^a   Doull, L J M ^a   Becq, F ^a   McPherson, M A ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

CFTR; DelF508; Human airway cells; Immunolocalisation; Pharmacology; Trafficking

Indexed keywords

ADENOSINE TRIPHOSPHATE MAGNESIUM; CALCIUM ION; CD59 ANTIGEN; MEMBRANE PROTEIN; MPB 07; MPB 91; MUTANT PROTEIN; QUINOLIZINE DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

APICAL MEMBRANE; ARTICLE; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG TARGETING; ENDOPLASMIC RETICULUM; FACILITATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

CALCIUM; CELL POLARITY; CELLS, CULTURED; CHLORIDES; CYCLIC AMP; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENZYME INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; IODIDES; QUINOLIZINES; RESPIRATORY MUCOSA;

EID: 0035203949     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity
2. Integration of endoplasmic reticulum signaling in health and disease
3. Activation of DeltaF508 CFTR in an epithelial monolayer
4. Phosphatase inhibitors activate normal and defective CFTR chloride channels
5. Development of substituted Benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel
6. Regulation of plasma membrane recycling by CFTR
7. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
8. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells
9. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
10. Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia
11. Submucosal glands are the predominant site of CFTR expression in the human bronchus
12. The substituted benzimidazolone NS004 is an opener of the cystic fibrosis chloride channel
13. cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein
14. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis
15. Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland
16. Activation of endogenous deltaF508 cystic fibrosis transmembrane conductance regulator by phosphodiesterase inhibition
17. Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by butyrate and phenylbutyrate
18. An antibody against a CFTR-derived synthetic peptide, incorporated into living submandibular cells, inhibits beta-adrenergic stimulation of mucin secretion
19. Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate
20. Defective beta-adrenergic secretory responses in submandibular acinar cells from cystic fibrosis patients
21. Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells
22. Actions of adenosine A1 and A2 receptor antagonists on CFTR antibody-inhibited beta-adrenergic mucin secretion response
23. Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium
24. The cystic fibrosis transmembrane conductance regulator
25. Identification of the cystic fibrosis gene: Cloning and characterization of complementary cDNA
26. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR
27. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation
28. Pharmacology of CFTR chloride channel activity
29. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis
30. Altered protein folding may be the molecular basis of most cases of cystic fibrosis
31. A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells
32. Inhibition of volume-regulated anion channels by expression of the cystic fibrosis transmembrane conductance regulator
33. Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR
34. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment
35. A cystic fibrosis bronchial epithelial cell line: Immortalization by adeno-12-SV40 infection